News archive
https://amr-accelerator.eu/wp-content/uploads/2021/10/unite4tb-4.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-10-25 15:59:152025-01-23 16:00:4625/10/24 – Managing Adverse Events in TB Care: Key Insights UNITE4TB Webinar
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_RespiriNTM-1.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-10-24 14:18:522024-10-24 14:18:5222/10/24 – BioVersys Joins RespiriNTM to Accelerate Development of the Broad-Spectrum Drug Candidates Against NTM Pulmonary Diseases
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_ERA4TB.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-10-22 15:11:322025-01-23 15:15:2722/10/24 – ERA4TB researchers win prestigious Quality Innovation Award
https://amr-accelerator.eu/wp-content/uploads/2021/10/unite4tb-4.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-10-14 15:58:182025-01-23 15:59:0614/10/24 – UNITE4TB Webinar: Intersecting the vulnerabilities of TB in migrants
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_GNANOW.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-10-02 11:54:472025-01-15 13:07:3102/10/24 – GNA NOW Annual & Expert Meeting
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_COMBINE.png
217
229
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-10-01 11:51:162024-10-01 11:51:1625/09/24 – The COMBINE Project Coordinator, Anders Karlén is Pharmacist of the Year 2024
https://amr-accelerator.eu/wp-content/uploads/2024/11/PRIMAVERA_ECRI-banner.png
250
800
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-09-24 15:25:022025-11-05 11:02:1424/09/2024 Sustaining European Antibiotics Through R&D Funding
https://amr-accelerator.eu/wp-content/uploads/2021/10/unite4tb-4.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-09-23 15:50:462025-01-23 15:57:5123/09/24 – Sustainable Funding Needed to Preserve EU AMR & Tuberculosis R&D
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_ERA4TB.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-09-23 15:07:222025-01-23 15:10:1223/09/24 – Sustainable funding required to protect early phase antibiotics R&D for TB and beyond.
https://amr-accelerator.eu/wp-content/uploads/2024/09/AMR-Accelerator_logos_preview-e1727427290812.jpg
768
1027
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-09-18 14:45:432025-06-27 16:18:10The AMR Accelerator calls to action: European capacity for antibiotic R&D requires long-term funding
https://amr-accelerator.eu/wp-content/uploads/2020/09/Circle_ERA4TB.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-09-02 16:31:532024-09-02 18:12:2830/08/24 – ERA4TB to host workshop on TB Drug Development at The Union Conference 2024
https://amr-accelerator.eu/wp-content/uploads/2021/10/unite4tb-4.png
217
230
m.reich
/wp-content/uploads/2024/08/IMI-AMR-Accelerator_Slogan_quer_RGB.png
m.reich2024-09-02 16:28:032024-09-02 16:28:0322/08/24 – UNITE4TB webinar: Management of adverse events in TB care